STOCK TITAN

[SCHEDULE 13G/A] RenovoRx, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

AWM Investment Company, Inc. reports beneficial ownership of 1,870,225 shares of RenovoRx common stock, representing 5.1% of the class. AWM is the investment adviser to three funds that together hold the shares and, as adviser, holds sole voting and dispositive power over the position. The reported holdings break down to 1,064,431 shares held by Special Situations Fund III QP, 296,698 shares held by Special Situations Cayman Fund, and 509,096 shares held by Special Situations Life Sciences Fund.

The filing includes a certification that the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

AWM Investment Company, Inc. dichiara la titolarità beneficiaria di 1.870.225 azioni della RenovoRx common stock, corrispondenti a il 5,1% della classe. AWM è la società di gestione di tre fondi che detengono congiuntamente queste azioni e, in qualità di consulente, detiene il potere esclusivo di voto e di disposizione sulla posizione. Le partecipazioni sono così suddivise: 1.064.431 azioni detenute da Special Situations Fund III QP, 296.698 azioni detenute da Special Situations Cayman Fund e 509.096 azioni detenute da Special Situations Life Sciences Fund.

La comunicazione include una certificazione che i titoli sono detenuti nell'ordinaria attività d'impresa e non sono stati acquisiti con l'intento di modificare o influenzare il controllo dell'emittente.

AWM Investment Company, Inc. informa la propiedad beneficiaria de 1.870.225 acciones de RenovoRx common stock, que representan el 5,1% de la clase. AWM es la asesora de inversión de tres fondos que, en conjunto, poseen las acciones y, como asesora, tiene el poder exclusivo de voto y disposición sobre la posición. Las participaciones se desglosan en 1.064.431 acciones mantenidas por Special Situations Fund III QP, 296.698 acciones por Special Situations Cayman Fund y 509.096 acciones por Special Situations Life Sciences Fund.

La presentación incluye una certificación de que los valores se mantienen en el curso ordinario del negocio y no se adquirieron para cambiar o influir en el control del emisor.

AWM Investment Company, Inc.는 RenovoRx 보통주의 1,870,225주에 대한 실질적 소유를 보고했으며, 이는 해당 종류의 5.1%에 해당합니다. AWM은 해당 주식을 함께 보유한 세 개 펀드의 투자 자문사이며, 자문사로서 이 포지션에 대해 단독 의결권 및 처분권을 보유하고 있습니다. 보유 내역은 Special Situations Fund III QP가 1,064,431주, Special Situations Cayman Fund가 296,698주, Special Situations Life Sciences Fund가 509,096주를 보유하고 있습니다.

해당 신고서에는 증권이 영업 과정에서 보유된 것이며 발행인의 지배권을 변경하거나 영향력을 행사하기 위해 취득된 것이 아님을 확인하는 인증서가 포함되어 있습니다.

AWM Investment Company, Inc. rapporte la propriété bénéficiaire de 1 870 225 actions de RenovoRx common stock, représentant 5,1 % de la catégorie. AWM est le conseiller en investissement de trois fonds qui détiennent ensemble ces actions et, en tant que conseil, dispose du pouvoir exclusif de vote et de disposition sur la position. Les avoirs se ventilent comme suit : 1 064 431 actions détenues par Special Situations Fund III QP, 296 698 actions détenues par Special Situations Cayman Fund et 509 096 actions détenues par Special Situations Life Sciences Fund.

Le dépôt comprend une attestation indiquant que les titres sont détenus dans le cours normal des affaires et n'ont pas été acquis dans le but de modifier ou d'influencer le contrôle de l'émetteur.

AWM Investment Company, Inc. meldet die wirtschaftliche Eigentümerschaft an 1.870.225 Aktien der RenovoRx-Stammaktien, was 5,1% der Klasse entspricht. AWM ist Anlageberater von drei Fonds, die die Aktien gemeinsam halten, und hat als Berater die alleinige Stimm- und Verfügungsgewalt über die Position. Die Bestände teilen sich wie folgt auf: 1.064.431 Aktien gehalten vom Special Situations Fund III QP, 296.698 Aktien vom Special Situations Cayman Fund und 509.096 Aktien vom Special Situations Life Sciences Fund.

Die Einreichung enthält eine Bescheinigung, dass die Wertpapiere im normalen Geschäftsverlauf gehalten werden und nicht zum Zweck des Erwerbs zur Änderung oder Beeinflussung der Kontrolle des Emittenten erworben wurden.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Disclosure shows a >5% aggregated stake managed by AWM with sole voting and investment power, a routine but material ownership filing.

AWM's 5.1% position crosses the reporting threshold and consolidates voting and dispositive authority across three affiliated funds. This filing is informational: it updates the market on ownership concentration rather than announcing transactions, financing, or strategic changes. For investors, the key point is centralized control by an adviser over a modest but reportable stake, which can affect shareholder dynamics if combined with other holders.

TL;DR: AWM holds sole voting and dispositive power for a >5% stake across affiliated funds; filing signals adviser-led control of shares.

The filing clarifies the allocation of voting and investment authority among AWM and its principals. Identification of sole voting and dispositive power is important for governance transparency because it shows who can vote shares on proxy matters. The certification that holdings are in the ordinary course reduces concerns about an immediate control intent, but the consolidated authority is relevant for board-related votes or proxy contests.

AWM Investment Company, Inc. dichiara la titolarità beneficiaria di 1.870.225 azioni della RenovoRx common stock, corrispondenti a il 5,1% della classe. AWM è la società di gestione di tre fondi che detengono congiuntamente queste azioni e, in qualità di consulente, detiene il potere esclusivo di voto e di disposizione sulla posizione. Le partecipazioni sono così suddivise: 1.064.431 azioni detenute da Special Situations Fund III QP, 296.698 azioni detenute da Special Situations Cayman Fund e 509.096 azioni detenute da Special Situations Life Sciences Fund.

La comunicazione include una certificazione che i titoli sono detenuti nell'ordinaria attività d'impresa e non sono stati acquisiti con l'intento di modificare o influenzare il controllo dell'emittente.

AWM Investment Company, Inc. informa la propiedad beneficiaria de 1.870.225 acciones de RenovoRx common stock, que representan el 5,1% de la clase. AWM es la asesora de inversión de tres fondos que, en conjunto, poseen las acciones y, como asesora, tiene el poder exclusivo de voto y disposición sobre la posición. Las participaciones se desglosan en 1.064.431 acciones mantenidas por Special Situations Fund III QP, 296.698 acciones por Special Situations Cayman Fund y 509.096 acciones por Special Situations Life Sciences Fund.

La presentación incluye una certificación de que los valores se mantienen en el curso ordinario del negocio y no se adquirieron para cambiar o influir en el control del emisor.

AWM Investment Company, Inc.는 RenovoRx 보통주의 1,870,225주에 대한 실질적 소유를 보고했으며, 이는 해당 종류의 5.1%에 해당합니다. AWM은 해당 주식을 함께 보유한 세 개 펀드의 투자 자문사이며, 자문사로서 이 포지션에 대해 단독 의결권 및 처분권을 보유하고 있습니다. 보유 내역은 Special Situations Fund III QP가 1,064,431주, Special Situations Cayman Fund가 296,698주, Special Situations Life Sciences Fund가 509,096주를 보유하고 있습니다.

해당 신고서에는 증권이 영업 과정에서 보유된 것이며 발행인의 지배권을 변경하거나 영향력을 행사하기 위해 취득된 것이 아님을 확인하는 인증서가 포함되어 있습니다.

AWM Investment Company, Inc. rapporte la propriété bénéficiaire de 1 870 225 actions de RenovoRx common stock, représentant 5,1 % de la catégorie. AWM est le conseiller en investissement de trois fonds qui détiennent ensemble ces actions et, en tant que conseil, dispose du pouvoir exclusif de vote et de disposition sur la position. Les avoirs se ventilent comme suit : 1 064 431 actions détenues par Special Situations Fund III QP, 296 698 actions détenues par Special Situations Cayman Fund et 509 096 actions détenues par Special Situations Life Sciences Fund.

Le dépôt comprend une attestation indiquant que les titres sont détenus dans le cours normal des affaires et n'ont pas été acquis dans le but de modifier ou d'influencer le contrôle de l'émetteur.

AWM Investment Company, Inc. meldet die wirtschaftliche Eigentümerschaft an 1.870.225 Aktien der RenovoRx-Stammaktien, was 5,1% der Klasse entspricht. AWM ist Anlageberater von drei Fonds, die die Aktien gemeinsam halten, und hat als Berater die alleinige Stimm- und Verfügungsgewalt über die Position. Die Bestände teilen sich wie folgt auf: 1.064.431 Aktien gehalten vom Special Situations Fund III QP, 296.698 Aktien vom Special Situations Cayman Fund und 509.096 Aktien vom Special Situations Life Sciences Fund.

Die Einreichung enthält eine Bescheinigung, dass die Wertpapiere im normalen Geschäftsverlauf gehalten werden und nicht zum Zweck des Erwerbs zur Änderung oder Beeinflussung der Kontrolle des Emittenten erworben wurden.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Cayman Fund, L.P. (CAYMAN), Special Situations Fund III QP, L.P. (SSFQP) and Special Situations Life Sciences Fund, L.P. (SSLS). (CAYMAN, SSFQP, and SSLS will hereafter be referred to as the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 1,064,431 shares of Common Stock of the Issuer (the Shares) held by SSFQP, 296,698 shares of Common Stock held by CAYMAN and 509,096 shares of Common Stock held by SSLS


SCHEDULE 13G



AWM Investment Company, Inc.
Signature:Adam Stettner
Name/Title:Executive Vice President
Date:06/30/2025

FAQ

What percentage of RenovoRx (RNXT) does AWM Investment Company, Inc. report owning?

AWM reports beneficial ownership of 1,870,225 shares, representing 5.1% of the class.

Which funds hold the RenovoRx shares reported by AWM?

The shares are held by Special Situations Fund III QP (1,064,431 shares), Special Situations Cayman Fund (296,698 shares), and Special Situations Life Sciences Fund (509,096 shares).

Does AWM have voting control over the reported RenovoRx shares?

Yes. AWM, as investment adviser to the funds, reports sole voting power and sole dispositive power over the reported shares.

Was the position reported as acquired to influence control of RenovoRx?

No. The filing includes a certification that the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

Does the filing indicate any group affiliation or joint filing?

No. The filing indicates no shared voting or dispositive power and does not identify any group with shared ownership.
Renovorx Inc

NASDAQ:RNXT

RNXT Rankings

RNXT Latest News

RNXT Latest SEC Filings

RNXT Stock Data

40.23M
32.36M
4.42%
27.55%
0.32%
Biotechnology
Pharmaceutical Preparations
Link
United States
MOUNTAIN VIEW